SCHEMBL25528882

SCHEMBL25528882

Cc1ccnc2ccc(-c3c(-c4ccc(F)cc4)nc(N)/c(=N/N)n3N)cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ HCRTR1 O43613 1/20 0.39
▸ USP2 O75604 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39
▸ MAPK14 Q16539 9/20 0.39
▸ MAPK13 O15264 2/20 0.39
▸ MAPK12 P53778 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25528944 0.89 KDM4E (0.36) SMN1; SMN2KDM4ENPC1HCRTR1USP2
SCHEMBL25528998 0.82 ADORA2A (0.41) SMN1; SMN2KDM4ENPC1HCRTR1USP2
SCHEMBL25206204 0.79 MAPK14 (0.40) SMN1; SMN2KDM4ENPC1HCRTR1USP2
SCHEMBL30359478 0.79 MAPK14 (0.40) SMN1; SMN2KDM4ENPC1HCRTR1USP2
SCHEMBL20600598 0.78 GRIA1 (0.48) CCNA2CDK2CSNK1ECDK5CDK5R1
SCHEMBL25528890 0.78 MAPK14 (0.47) MAPK1MAPK14MAPK13MAPK12MAPK11
SCHEMBL20666043 0.76 MAPK14 (0.43) SMN1; SMN2KDM4ENPC1HCRTR1USP2
SCHEMBL20600523 0.75 GRIA1 (0.39) SMN1; SMN2KDM4ENPC1HCRTR1USP2
SCHEMBL25528249 0.74 ADORA2A (0.52) —
SCHEMBL20624497 0.74 GRIA1 (0.40) SMN1; SMN2KDM4ENPC1HCRTR1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023091604-A1 ADENOSINE RECEPTOR ANTAGONISTS CROSSIGNAL THERAPEUTICS, INC. (US) 2023-05-25 — — WO disclosed
Send feedback